Approval · Notice of Compliance 1918 · 1999
NASONEX: Notice of Compliance 1918
Issued August 23, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1918
- Date
- August 23, 1999
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New pediatric indication: for use in children between the ages of 3 and 11 years to treat the symptoms of seasonal or perennial allergic rhinitis
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NASONEX | Not yet assigned | — |
Medicinal ingredients
- MOMETASONE FUROATE 5 MCG per ACT